2004
DOI: 10.2169/internalmedicine.43.869
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent Small-Artery Disease in Hyperhomocysteinemia: Widowers' Stroke Syndrome?

Abstract: Hyperhomocysteinemia is thought to cause ischemic strokes. We report two middle-aged widowers with frequent recurrences of small-artery strokes, two capsular infarcts and a thalamic hemorrhage in one patient, and two thalamic and pontine infarcts in the other. Blood tests following the final stroke showed hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T gene mutation, with low concentration of vitamin B6. Multivitamin supplementation normalized plasma homocysteine levels in both patients. Hyp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 19 publications
1
8
0
Order By: Relevance
“…Hyperhomocysteinemia is well known to be associated with elevated IS risk [34]. In line with our ndings, many prior studies have con rmed elevated HCY levels to be associated with IS risk in younger patient populations [35][36][37][38], with this correlation being strongest in younger individuals [35]. The risk of IS has been shown to be roughly two-fold higher in IS patients with high HCY levels relative to patients with low HCY levels [39,40].…”
Section: Discussionsupporting
confidence: 78%
“…Hyperhomocysteinemia is well known to be associated with elevated IS risk [34]. In line with our ndings, many prior studies have con rmed elevated HCY levels to be associated with IS risk in younger patient populations [35][36][37][38], with this correlation being strongest in younger individuals [35]. The risk of IS has been shown to be roughly two-fold higher in IS patients with high HCY levels relative to patients with low HCY levels [39,40].…”
Section: Discussionsupporting
confidence: 78%
“…Reduction of MTHFR enzyme activity increases the pool of 5,10-methylenetetrahydrofolate (5,10-methylene-THF) at the expense of the pool of 5-methyltetrahydrofolate (5-methyl-THF), which is used as a methyl donor in the synthesis of methionine from homocysteine (Toyoda et al, 2004). In turn, methionine provides the methyl group for the formation of S-adenosylmethionine, which is involved in numerous cellular reactions, including DNA, RNA and histone methylation.…”
Section: Introductionmentioning
confidence: 99%
“…The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) irreversibly catalyzes the reduction of 5,10-methylenetetrahydrofolate (5,10-methylene-THF) to 5-methyltetrahydrofolate (5-methyl-THF), which is used as a methyl donor in the synthesis of methionine from homocysteine (Toyoda et al, 2004). In turn, methionine provides the methyl group for the formation of S-adenosylmethionin, which is involved in numerous cellular reactions involving DNA, RNA, and histone methylation.…”
Section: Introductionmentioning
confidence: 99%